Janssen Pharmaceutica N.V. v. Eon Labs Manufacturing, Inc.
This text of 112 F. App'x 7 (Janssen Pharmaceutica N.V. v. Eon Labs Manufacturing, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
ORDER
We consider whether 04-1566 should be dismissed.
04-1539 represents Janssen Pharmaceutical N.V. et al.’s (Janssen) appeal of the judgment of the United States District Court for the Eastern District of New York. Subsequently, Janssen filed a “supplemental notice of appeal” seeking review of the district court’s August 25, 2004 order. Janssen’s “supplemental notice of appeal” should have been treated as an amended notice of appeal but was instead docketed as a new appeal, 04-1566. Because 04-1566 should not have been docketed as a separate appeal, we dismiss.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) 04-1566 is dismissed.
(2) The revised official caption for 04-1539, -1576 is reflected above.
(3) Each side shall bear its own costs.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
112 F. App'x 7, Counsel Stack Legal Research, https://law.counselstack.com/opinion/janssen-pharmaceutica-nv-v-eon-labs-manufacturing-inc-cafc-2004.